BrainsWay to Invest $1.5M in Hopemark Health with $3M Milestone Potential
BrainsWay will invest $1.5 million initially, with potential for an additional $1.5 million via milestone-based preferred security to acquire a minority stake in Hopemark Health, a Chicago-area mental health clinic operator. The financing deal includes a share redemption mechanism to support BrainsWay’s expansion of Deep TMS access and awareness.
1. Investment Terms
BrainsWay will invest $1.5 million initially and may provide a further $1.5 million through milestone-based preferred, annually compounding securities for a minority position in Hopemark Health. The agreement also includes a redemption mechanism for the preferred shares, ensuring flexibility in the equity stake.
2. Strategic Rationale
This minority-stake financing aligns with BrainsWay’s strategy to partner with growth-oriented clinical platforms to expand awareness and access to its Deep Transcranial Magnetic Stimulation technology. Hopemark Health manages multiple outpatient mental health clinics in the greater Chicago area, offering a ready network for advanced interventional psychiatry solutions.
3. Expected Impact
The investment is designed to accelerate patient adoption of Deep TMS treatments and reinforce operational best practices at Hopemark clinics. By combining growth capital with BrainsWay’s technical expertise, the partnership aims to strengthen BrainsWay’s market presence and drive long-term value creation in outpatient psychiatric care.